Disc JPM Final Presentation_2026.pdf

1、J.P.Morgan44thAnnual Healthcare ConferenceCorporate OverviewJanuary 20262Disclaimer and FLSThis presentation contains“forward-looking statements”within the meaning of the Private Securities Litigation Reform Act of 1995,including,but not limited to,express or implied statements regarding Discs expec

2、tations with respect to its preclinical studies,clinical trials and research and development programs,in particular with respect to bitopertin,DISC-0974 and DISC-3405,and any developments or results in connection therewith;projected timelines for the initiation and completion of its clinical trials,

3、anticipated timing of release of data,and other clinical activities;the registrational pathway for bitopertin,including the potential for accelerated approval,benefits of the CNPV,expected review period and timing of approval,if granted;anticipated discussions with regulatory agencies;Discs expectat

4、ions with respect to the potential launch and commercialization of bitopertin,if approved;the market and potential opportunities for bitopertin,DISC-0974 and DISC-3405;the potential of Discs development programs in new indications;Discs preliminary unaudited cash,cash equivalents and marketable secu

5、rities as of December 31,2025;and the time period over which Discs capital resources will be sufficient to fund its anticipated operations.The use of words such as,but not limited to,“believe,”“expect,”“estimate,”“project,”“intend,”“future,”“potential,”“continue,”“may,”“might,”“plan,”“will,”“should,

6、”“seek,”“anticipate,”or“could”or the negative of these terms and other similar words or expressions that are intended to identify forward-looking statements.Forward-looking statements are neither historical facts nor assurances of future performance.Instead,they are based on Discs current beliefs,ex